Nearly half of women at risk of preterm birth do not receive cheap drug that could prevent millions of newborn deaths

August 13, 2014

A major international study of more than 303 000 births in 29 low-income and middle-income countries has found that only half (52%) of women who are eligible to receive a simple, effective, low-cost treatment to prevent death and disability in their newborn babies are getting it.

The findings, published in The Lancet, highlight striking gaps in the practice of using antenatal (before birth) steroid injections—known to significantly reduce the risk of death, respiratory distress syndrome (a consequence of immature lung development), cerebroventricular haemorrhage (bleeding in the ventricles of the brain), and long-term complications such as cerebral palsy and poor motor skills—prior to preterm birth.

Use of antenatal corticosteroids was highly variable ranging from 16–20% of eligible in Afghanistan, the Democratic Republic of Congo, Nepal, and Niger which have particularly high rates of neonatal deaths, to 91% in Jordan and 88% in the Occupied Palestinian territory. For more detailed findings by country see table 2 page 4.

An estimated 15 million babies (more than one in 10) are born prematurely every year. Around 1 million children die each year due to complications of preterm birth. Many survivors face a lifetime of disability, including learning disabilities and visual and hearing problems.

"Giving antenatal corticosteroids to women at risk of is one of the most effective treatments for reducing newborn death and illness. More than three-quarters of premature babies could be saved with cost-effective interventions such as antenatal corticosteroids. This is particularly important in Africa and Asia where more than 60% of preterm deliveries occur and where resources are scarce and it is difficult to provide expensive neonatal care", said study leader Dr Joshua Vogel from the Department of Reproductive Health and Research at WHO in Geneva.

Using data from the WHO Multicountry Survey on Maternal and Newborn Health (WHOMCS), the researchers looked at patterns of antenatal corticosteroid use in preterm births and tocolytic drugs (to delay delivery) in spontaneous preterm births among 303 842 births that took place in 359 hospitals in 29 countries.

The analysis showed that a substantial proportion of antenatal corticosteroid use occurred in women who delivered at gestational ages at which benefit is controversial (19% at 22 weeks, and 24% at 34 weeks). Of women most likely to benefit (who gave between 26 and 34 weeks gestation), only half (52%) received them.

Worryingly, almost half of women with uncomplicated, spontaneous preterm labour who were eligible for tocolytic drugs received no treatment, while more than a third received ineffective treatments such as bed rest, hydration, and magnesium sulphate. Moreover, the use of less effective or potentially harmful tocolytic drugs such as beta-agonists was common and exposed women and their babies to unnecessary risk.

Dr Vogel explained, "Ideally, women in preterm labour between 26 and 34 weeks' gestation should receive antenatal corticosteroids, yet only 52% of eligible women received them. For women in spontaneous preterm labour, using tocolytic drugs can delay delivery and allow more time for antenatal corticosteroids to work, but only 18% of eligible women received both treatments and 42% received neither."*

The authors conclude by calling for the inclusion of corticosteroids (dexamethasone and/or betamethasone) on national essential medicines lists, alongside research evaluating the benefits and potential harms of changing prescribing practices to allow midwives to give these drugs.

Writing in a linked Comment, Stuart Dalziel, Caroline Crowther, and Jane Harding from The University of Auckland in New Zealand say, "Antenatal corticosteroids are not the panacea for preterm mortality in low-income and middle-income countries. Rather, the drugs should be included in a set of simple efficacious measures—family planning, access to antenatal care, antibiotic drugs for premature rupture of membranes, immediate and simple care for all babies, effective neonatal resuscitation, and kangaroo mother care…Future research should not focus on efficacy but on strategies to reduce barriers for appropriate use of . The WHOMCS approach would allow monitoring of progress. Let us not wait another 40 years to translate evidence into global practice."

Explore further: Courses of prenatal corticosteroids not associated with increased death of children

More information: The Lancet, www.thelancet.com/journals/lan … (14)60580-8/abstract

Related Stories

Courses of prenatal corticosteroids not associated with increased death of children

October 14, 2013
Multiple courses of prenatal corticosteroids, compared with a single course, taken by pregnant women to help prevent preterm birth was associated with no increase or decrease in the risk of death or disability for their children ...

Preterm delivery, low birth weight and neonatal risk in pregnant women with high blood pressure

April 15, 2014
Pregnant women with chronic hypertension (high blood pressure) are highly likely to suffer from adverse pregnancy outcomes such as preterm delivery, low birth weight and neonatal death, which highlights a need for heightened ...

Is delaying premature delivery safe? Professor questions the use of drugs that delay premature birth

October 9, 2012
Professor Alfirevic from the Department of Women's and Children's Health at the University of Liverpool argues that although premature children tend to have lower cognitive ability than their peers and 14.9 million are born ...

Steroids increase viability of preemies as young as 22 weeks

December 6, 2011
With chubby cheeks and weighing in at a healthy 10 pounds, the imminently huggable Lexi Morrison is far removed from the 1-pound, 9 –ounce preemie she was in June when she was born premature at 24 weeks.

PTSD, major depressive episode appears to increase risk of preterm birth

June 11, 2014
Diagnoses of both posttraumatic stress disorder (PTSD) and a major depressive episode appear to be associated with a sizable increase in risk for preterm birth that seems to be independent of antidepressant and benzodiazepine ...

Recommended for you

Women exposed to smoke while in womb more likely to miscarry

July 13, 2017
Women exposed to cigarette smoke while in their mothers' wombs are more likely to experience miscarriage as adults, according to new research from the University of Aberdeen.

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Aspirin reduces risk of pre-eclampsia in pregnant women

June 28, 2017
Taking a low-dose aspirin before bed can reduce the risk of pre-eclampsia, which can cause premature birth and, in extreme cases, maternal and foetal death.

The biology of uterine fluid: How it informs the fetus of mom's world

June 22, 2017
A developing fetus bathes in a mixture of cellular secretions and proteins unique to its mother's uterus. Before fertilization, the pH of uterine fluid helps create a conducive environment for sperm migration, and afterward, ...

New clues in puzzle over pre-eclampsia and cholesterol regulation

June 21, 2017
Scientists studying a mystery link between the dangerous pregnancy complication pre-eclampsia and an increased risk of heart disease in later life for both mother and child have uncovered important new clues.

Are maternal hormones different when carrying a boy or a girl?

June 15, 2017
With advances in prenatal testing it's now possible to find out whether a pregnancy will result in a male or female baby as early as eight weeks' gestation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.